Intravenous administration of mesenchymal stem cells exerts therapeutic effects on parkinsonian model of rats: focusing on neuroprotective effects of stromal cell-derived factor-1alpha.

Source:http://linkedlifedata.com/resource/pubmed/id/20420688

Download in:

View as

General Info

PMID
20420688